Children with diabetes now have a needle-free insulin option as the FDA approves Afrezza, the first fast-acting inhaled ...
The insulin crisis in America has left millions rationing doses; here are 10 facts you need to know. The post 10 facts about ...
Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use ...
Click in for more news from The Hill {beacon} Health Care   The Big Story  Insulin legislation gains steam  Bipartisan ...
Your blood work looks great! Your cholesterol, A1C and fasting glucose are all in the healthy range. But your fitness tracker ...
The Inflation Reduction Act's attempt to improve insulin costs for Medicare beneficiaries-by capping out-of-pocket costs at ...
On Friday, the FDA expanded its approved use for kids 6 years and older who have Type 1 diabetes or those who require insulin ...
By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to ...
Today millions of diabetic patients across the world do not have access to insulin. Why and how can governments reverse this ...
A large proportion of people living with type 2 diabetes treated with basal insulin therapy remain inadequately controlled ...
The FDA approved an inhaled needle-free insulin and a Delaware County teenager was part of the four year clinical trial.
For patients who want a closer look at metabolic risk, several specialized tests go beyond standard glucose measurements.